Business ❯ Healthcare ❯ Pharmaceuticals

Oncology

Clinical Trials Drug Development Keytruda Pediatric Cancer Cancer Immunotherapy Precision Medicine Product Development Antibody-Drug Conjugates Cisplatin-Induced Ototoxicity Myelofibrosis Antibody Drug Conjugates Research and Development Darzalex Cancer Medicines Targeted Therapies Cancer Drugs Chronic Myeloid Leukaemia Guardant Health Collaboration Partnerships Acute Leukaemia Speciality Care Drug Sales Growth Lung Cancer Drug Delivery Devices Sales Performance CAR-T Therapies Data Collaboration Johnson & Johnson Gastrointestinal Cancers

Pfizer and Innovent Strike Up to $10.5 Billion Oncology Collaboration

Backed by a $650 million up-front payment, the agreement places Pfizer in charge of global development for a 12-program cancer portfolio discovered and advanced by Innovent.

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Gilead Expands Tempus Partnership for Enterprise Access to AI Oncology Platform

Gilead to Acquire Tubulis for Up to $5 Billion to Boost Cancer ADC Pipeline

Karyopharm Raises $30 Million in RA Capital Private Placement

C-Further Launches First Pediatric Cancer Programs, Taps MiNK for PRAME iNKT Therapy

Merck Lifts Mid-2030s Revenue Goal to $70 Billion From Emerging Businesses

Merck Reportedly Weighs $28–$32 Billion Deal for Revolution Medicines After AbbVie Denial

Amgen Buys Oxford Spinout Dark Blue Therapeutics for Up to $840 Million

J&J to Spin Off $9 Billion Orthopedics Unit as DePuy Synthes Within Two Years

Pfizer Lifts 2025 EPS Outlook, Targets $7.7 Billion in Savings as Dividend Draws Interest